Polycystic ovary syndrome (PCOS)
Exam relevance: in 15 of more than 150 board exam reports · rank 49
- Synonyms
- polycystic ovary syndrome, PCOS, polycystic ovaries
- Specialty
- Gynaecology · Endocrinology & cycle
- Images
- Ultrasound 1 · Clinical 3
- Exam relevance
- 15 of more than 150 reports · rank 49
- In the app
- 2 flashcards · GynFuchs
- Last updated
- 11/2026 · Dr. Pascal Bafteh
Contents
Images (4)
Ultrasound


Definition
Rotterdam Criteria
- First criterion: oligo- and/or anovulation.
- Second criterion: clinical and/or biochemical hyperandrogenism.
- Third criterion: polycystic ovaries (ultrasound).
- What is additionally required: exclusion of other causes (diagnosis of exclusion).
- In adolescents in the first few years after menarche: ultrasound criterion does not apply.
Occurrence & epidemiology
- PCOS is the most common hormonal disorder in women of reproductive age: by the Rotterdam criteria about 10–13 % are affected worldwide.
- PCOS is common in all ethnic groups, and prevalence is broadly similar across world regions, possibly somewhat higher in South East Asia and the Eastern Mediterranean; the presentation may differ between ethnic groups.
- The syndrome accompanies those affected across the lifespan, from adolescence to after the menopause.
Aetiopathogenesis
- The cause is complex and not fully understood. Obesity, physical inactivity, inflammation and epigenetic changes may aggravate the condition.
- Many women with PCOS have insulin resistance with raised insulin levels, regardless of body weight and androgen levels. Insulin increases androgen production in the ovary.
- When LH is high, the theca cells of the ovary produce more androgens. If FSH is relatively low at the same time, no dominant follicle may be selected: ovulation fails, and many small follicles arrest in their growth.
Clinical features
What Belongs to PCOS but Is Not in the Criteria
- Pathogenetically central: insulin resistance with hyperinsulinaemia.
- Further risks: dyslipidemia, hypertension, fatty liver.
- Long-term gynaecological risk: endometrial hyperplasia to carcinoma.
Differentiating the Terms
- Hirsutism: terminal hair at androgen-dependent sites.
- Hypertrichosis: androgen-independent hair growth, often drug-induced.
- Virilisation: hirsutism plus clitoromegaly, voice deepening.
- How hirsutism is graded: using the Ferriman-Gallwey score (9 body regions).
- What rapid progression with virilisation means: suspicion of androgen-producing tumor (urgent workup!).
Associated conditions and risks
- Skin and hair: in adults, hirsutism is the strongest pointer to raised androgens. Acne and female-pattern hair loss on their own are only weak indicators.
- Metabolism: regardless of age and body weight, the risk of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes is increased. Cardiovascular risk is also considered increased, although it is low overall before the menopause.
- Mental health: depressive symptoms and anxiety disorders are considerably more common. Body image can be affected, and eating disorders occur regardless of weight.
- Sleep: obstructive sleep apnoea is considerably more common, also independently of body weight.
- Endometrium: before the menopause the risk of endometrial hyperplasia and endometrial cancer is markedly increased, but the absolute chance of endometrial cancer remains low.
- Pregnancy: women with PCOS have a higher risk of complications during pregnancy.
Diagnosis
Ovary on Ultrasound
- Follicle count criterion according to current definition: ≥ 20 follicles (2–9 mm) per ovary.
- Alternative criterion: ovarian volume > 10 ml (without follicle/corpus luteum).
- Typical distribution of follicles: string of pearls, subcapsular.
- Important clarification: PCO alone is not a syndrome.
Laboratory Findings and Their Interpretation
- Tests performed: testosterone, SHBG, FAI, DHEAS, LH, FSH, E2, PRL, TSH.
- Classic but not mandatory constellation: elevated LH-FSH ratio.
- Where ovarian androgens are produced: in the theca cells.
- Where DHEAS originates: from the adrenal cortex.
- What a markedly elevated testosterone necessitates: ruling out an androgen-producing tumour/CAH.
- Why AMH is often high: many small follicles produce AMH.
Treatment principles
- Treatment depends on the main symptoms and the wish for pregnancy; in women with excess weight, lifestyle change with weight reduction is the first step.
- If pregnancy is not desired, cycle disorders and hyperandrogenism are treated with combined hormonal contraceptives, supplemented with antiandrogens if necessary.
- If pregnancy is desired, ovulation induction, primarily with aromatase inhibitors, is the next step, followed by gonadotrophins or assisted reproduction if needed; metabolic risks such as diabetes are assessed regularly.
Specific treatment regimens with drugs and doses are covered in the GynFuchs app.
Keep learning in the app
Further reading (selection)
Cross-references
Keep learning
Keep learning with flashcards, exam questions and spot diagnoses in the GynFuchs app – free, in your browser or as an app.
Related pages: Postmenopausal osteoporosis · Premature ovarian insufficiency (POI) · Premenstrual syndrome (PMS/PMDD)
Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.